Zdrowie i gospodarka · 13.01.1994
Opportunity for a License for Nonpatented Material
The Centers for Disease Control and Prevention (CDC) is offering a license for recombinant proteins and synthetic peptides to be used as immunodiagnostic reagents for detecting Hepatitis C Virus (HCV) antibodies.